Alterations in the expression of nNOS in the substantia nigra and subthalamic nucleus of 6-OHDA-lesioned rats: The effects of chronic treatment with l-DOPA and the nitric oxide donor, molsidomine

Brain Research

Volumn 1541, Issue , 2013, Pages 92-105

  Czarnecka, Anna ^a   Lenda, Tomasz ^a   Domin, Helena ^a   Konieczny, Jolanta ^a   Śmiałowska, Maria ^a   Lorenc Koci, Elzbieta ^a  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

Author keywords

Hypertrophy; l DOPA; Nitric oxide; nNOS; Substantia nigra; Subthalamic nucleus

Indexed keywords

DOPAMINE; LEVODOPA; MOLSIDOMINE; NEURONAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE; OXIDOPAMINE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE DEHYDROGENASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASAL GANGLION; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; DRUG EFFECT; HYPERTROPHY; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LOW DRUG DOSE; MALE; NERVE DEGENERATION; NIGRONEOSTRIATAL SYSTEM; NITRERGIC NERVE; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RAT; ROTATIONAL ATHERECTOMY; STEREOLOGY; SUBSTANTIA NIGRA; SUBTHALAMIC NUCLEUS; WESTERN BLOTTING;

RATTUS;

6-HYDROXYDOPAMINE; 6-OHDA; CRESYL VIOLET; CV; HYPERTROPHY; L-DOPA; MEDIAL FOREBRAIN BUNDLE; MFB; MOL; MOLSIDOMINE; NADPH-D; NEURONAL NITRIC OXIDE SYNTHASE; NICOTINAMIDE DINUCLEOTIDE PHOSPHATE DIAPHORASE; NITRIC OXIDE; NNOS; NO; PARKINSON'S DISEASE; PD; SNC; SNR; STN; SUBSTANTIA NIGRA; SUBSTANTIA NIGRA PARS COMPACTA; SUBSTANTIA NIGRA PARS RETICULATA; SUBTHALAMIC NUCLEUS; TH; TYROSINE HYROXYLASE;

ADRENERGIC AGENTS; ANIMALS; ANTIPARKINSON AGENTS; BLOTTING, WESTERN; IMMUNOHISTOCHEMISTRY; LEVODOPA; MALE; MOLSIDOMINE; NADPH DEHYDROGENASE; NEURONS; NITRIC OXIDE DONORS; NITRIC OXIDE SYNTHASE TYPE I; OXIDOPAMINE; PARKINSONIAN DISORDERS; RATS; RATS, WISTAR; SUBSTANTIA NIGRA; SUBTHALAMIC NUCLEUS;

EID: 84888008252     PISSN: 00068993     EISSN: 18726240     Source Type: Journal    
DOI: 10.1016/j.brainres.2013.10.011     Document Type: Article

References (75)

1. A. Benazzouz, S. Breit, A. Koudsie, P. Pollak, P. Krack, and A.L. Benabid Intraoperative microrecordings of the subthalamic nucleus in Parkinson's disease Mov. Disord. 17 3 2002 145 149
2. R. Böckelmann, G Wolf, G. Ransmayr, and P. Riederer NADPH-diaphorase/nitric oxide synthase containing neurons in normal and Parkinson's disease putamen J. Neural Transm. Park. Dis. Dement. Sect. 7 2 1994 115 121
3. R.H. Böger, S.M. Bode-Böger, U. Gerecke, and J.C. Frölich Long-term administration of L-arginine, L-NAME, and the exogenous NO donor molsidomine modulates urinary nitrate and cGMP excretion in rats Cardiovasc. Res. 28 1994 494 499
4. D.S. Bredt, C.E. Glatt, P.M. Hwang, M. Fotuhi, T.M. Dawson, and S.H. Snyder Nitric oxide synthase protein and mRNA are discretely localized in neuronal populations of the mammalian CNS together with NADPH diaphorase Neuron 7 4 1991 615 624
5. D.S. Bredt, and S.H. Snyder Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme Proc. Natl. Acad. Sci. USA 87 2 1990 682 685
6. B. Buwalda, C. Nyakas, J. Gast, P.G. Luiten, and H.H. Schmidt Aldehyde fixation differentially affects distribution of diaphorase activity but not of nitric oxide synthase immunoreactivity in rat brain Brain Res. Bull. 38 5 1995 467 473
7. P. Calabresi, D. Centonze, P. Gubellini, G.A. Marfia, A. Pisani, G. Sancesario, and G. Bernardi Synaptic transmission in the striatum: from plasticity to neurodegeneration Prog. Neurobiol. 61 2000 231 265
8. M. Chalimoniuk, N. Lukacova, J. Marsala, and J. Langfort Alterations of the expression and activity of midbrain nitric oxide synthase and soluble guanylyl cyclase in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism in mice Neuroscience 141 2 2006 1033 1046
9. Y.C. Chung, S.R. Kim, and B.K. Jin Paroxetine prevents loss of nigrostriatal dopaminergic neurons by inhibiting brain inflammation and oxidative stress in an experimental model of Parkinson's disease J. Immunol. 185 2 2010 1230 1237
10. A. Contestabile, and E. Ciani Role of nitric oxide in the regulation of neuronal proliferation, survival and differentiation Neurochem. Int. 45 6 2004 903 914
11. A. Czarnecka, T. Lenda, J. Konieczny, H. Domin, K. Kamińska, and E. Lorenc-Koci Contribution of nitrergic transmission to the modulation of l-DOPA activity in the 6-OHDA model of Parkinson's disease. Therapeutic implications Park. Relat. Disord. 18 2012 197
12. T.M. Dawson, D.S. Bredt, M. Fotuhi, P.M. Hwang, and S.H. Snyder Nitric oxide synthase and neuronal NADPH diaphorase are identical in brain and peripheral tissues Proc. Natl. Acad. Sci. USA 88 17 1991 7797 7801
13. T.M. Dawson, V.L. Dawson, and S.H. Snyder A novel neuronal messenger molecule in brain: the free radical, nitric oxide Ann. Neurol. 32 3 1992 297 311
14. J. De Vente, D.A. Hopkins, M. Markerink-Van Ittersum, P.C. Emson, H.H. Schmidt, and H.W. Steinbusch Distribution of nitric oxide synthase and nitric oxide-receptive, cyclic GMP-producing structures in the rat brain Neuroscience 87 1 1998 207 241
15. J. De Vente, M. Markerink-van Ittersum, J. van Abeelen, P.C. Emson, H. Axer, and H.W. Steinbusch NO-mediated cGMP synthesis in cholinergic neurons in the rat forebrain: effects of lesioning dopaminergic or serotonergic pathways on nNOS and cGMP synthesis Eur. J. Neurosci. 12 2000 507 519
16. V. Di Matteo, M. Pierucci, A. Benigno, G. Crescimanno, E. Esposito, and G. Di Giovanni Involvement of nitric oxide in nigrostriatal dopaminergic system degeneration. Steroid enzymes and cancer Ann. N.Y. Acad. Sci. 1155 2009 309 315
17. D.J. Eve, A.P. Nisbet, A.E. Kingsbury, E.L. Hewson, S.E. Daniel, A.J. Lees, C.D. Marsden, and O.J. Foster Basal ganglia neuronal nitric oxide synthase mRNA expression in Parkinson's disease Brain Res. Mol. Brain Res. 63 1 1998 62 71
18. S. Fang, J. Christensen, J.L. Conklin, J.A. Murray, and G. Clark Roles of Triton X-100 in NADPH-diaphorase histochemistry J. Histochem. Cytochem. 42 11 1994 1519 1524
19. B.A. Faucheux, A.M. Bonnet, Y. Agid, and E.C. Hirsch Blood vessels change in the mesencephalon of patients with Parkinson's disease Lancet 353 1999 981 982
20. G. Figueredo-Cardenas, M. Morello, G. Sancesario, G. Bernardi, and A. Reiner Colocalization of somatostatin, neuropeptide Y, neuronal nitric oxide synthase and NADPH-diaphorase in striatal interneurons in rats Brain Res. 735 1996 317 324
21. L. Frau, M. Morelli, and N. Simola Performance of movement in hemiparkinsonian rats influences the modifications induced by dopamine agonists in striatal efferent dynorphinergic neurons Ex. Neurol. 247 2013 663 672
22. S. Gancher, and A. Mayer Sensitization to apomorphine-induced rotational behavior in 6-OHDA-lesioned rats: effects of NMDA antagonists on drug response Brain Res. 682 1995 63 68
23. J. Garthwaite Glutamate, nitric oxide and cell-cell signalling in the nervous system Trends Neurosci. 14 2 1991 60 67
24. J. Garthwaite Concepts of neural nitric oxide-mediated transmission Eur. J. Neurosci. 27 11 2008 2783 2802
25. M. Giorgi, G. Melchiorri, V. Nuccetelli, V. D'Angelo, A. Martorana, R. Sorge, V. Castelli, G. Bernardi, and G. Sancesario PDE10A and PDE10A-dependent cAMP catabolism are dysregulated oppositely in striatum and nucleus accumbens after lesion of midbrain dopamine neurons in rat: a key step in Parkinsonism physiopathology Neurobiol. Dis. 43 1 2011 293 303
26. M.Z. Gomes, and E.A. Del Bel Effects of electrolytic and 6-hydroxydopamine lesions of rat nigrostriatal pathway on nitric oxide synthase and nicotinamide adenine dinucleotide phosphate diaphorase Brain Res. Bull. 62 2 2003 107 115
27. T. González-Hernández, and M. Rodríguez Compartmental organization and chemical profile of dopaminergic and GABAergic neurons in the substantia nigra of the rat J. Comp. Neurol. 421 1 2000 107 135
28. H.J. Gundersen, E.B. Jensen, K. Kiêu, and J. Nielsen The efficiency of systematic sampling in stereology - reconsidered J. Microsc. 193 1999 199 211
29. O.K. Hassani, M. Mouroux, and J. Feger Increased subthalamic neuronal activity after nigral dopaminergic lesion independent of disinhibition via the globus pallidus Neuroscience 72 1996 105 115
30. B. Henry, A.R. Crossman, and J.M. Brotchie Characterization of enhanced behavioral responses to l-DOPA following repeated administration in the 6-hydroxydopamine-lesioned rat model of Parkinson's disease Exp. Neurol. 151 1998 334 342
31. B.T. Hope, G.J. Michael, K.M. Knigge, and S.R. Vincent Neuronal NADPH diaphorase is a nitric oxide synthase Proc. Natl. Acad. Sci. USA 88 7 1991 2811 2814
32. B.T. Hope, and S.R. Vincent Histochemical characterization of neuronal NADPH-diaphorase J. Histochem. Cytochem. 37 5 1989 653 661
33. K.E. Hoque, R.P. Indorkar, S. Sammut, and A.R. West Impact of dopamine-glutamate interactions on striatal neuronal nitric oxide synthase activity Psychopharmacology (Berlin) 207 4 2010 571 581
34. M.D. Johnson, and P.M. Ma Localization of NADPH diaphorase activity in monoaminergic neurons of the rat brain J. Comp. Neurol. 332 4 1993 391 406
35. Y. Kawaguchi Neostriatal cell subtypes and their functional roles Neurosci. Res. 27 1997 1 8
36. P.H. Kelly, and S.D. Iversen Selective 6OHDA-induced destruction of mesolimbic dopamine neurons: abolition of psychostimulant-induced locomotor activity in rats Eur. J. Pharmacol. 40 1976 45 56
37. V.N. Kharazia, H.H. Schmidt, and R.J. Weinberg Type I nitric oxide synthase fully accounts for NADPH-diaphorase in rat striatum, but not cortex Neuroscience 62 4 1994 983 987
38. W.K. Kim, Y.B. Choi, P.V. Rayudu, P. Das, W. Asaad, D.R. Arnelle, J.S. Stamler, and S.A. Lipton Attenuation of NMDA receptor activity and neurotoxicity by nitroxyl anion, NO- Neuron 24 1999 461 469
39. Y. Kubota, S. Mikawa, and Y. Kawaguchi Neostriatal GABAergic interneurones contain NOS, calretinin or parvalbumin Neuroreport 5 1993 205 208
40. M.A. Kuiper, J.J. Visser, P.L. Bergmans, P. Scheltens, and E.C. Wolters Decreased cerebrospinal fluid nitrate levels in Parkinson's disease, Alzheimer's disease and multiple system atrophy patients J. Neurol. Sci. 121 1 1994 46 49
41. U.K. Laemmli Cleavage of structural proteins during the assembly of the head of bacteriophage T4 Nature 227 1970 680 685
42. E.L. Lane, S.C. Cheetham, and P. Jenner Does contraversive circling in the 6-OHDA-lesioned rat indicate an ability to induce motor complications as well as therapeutic effects in Parkinson's disease? Exp. Neurol. 197 2006 284 290
43. H.S. Lindgren, K.E. Ohlin, and M.A. Cenci Differential involvement of D1 and D2 dopamine receptors in l-DOPA-induced angiogenic activity in a rat model of Parkinson's disease Neuropsychopharmacology 34 2009 2477 2488
44. R.E. Loiacono, and P.M. Beart Hippocampal lesions induced by microinjection of the nitric oxide donor nitroprusside Eur. J. Pharmacol. 216 2 1992 331 333
45. M. Maccario, S.E. Oleandri, M. Procopio, S. Grottoli, E. Avogadri, F. Camanni, and E. Ghigo Comparison among the effects of arginine, a nitric oxide precursor, isosorbide dinitrate and molsidomine, two nitric oxide donors, on hormonal secretions and blood pressure in man J. Endocrinol. Invest. 20 1997 488 492
46. R. Martinez-Murillo, R. Villalba, M.I. Montero-Caballero, and J. Rodrigo Cholinergic somata and terminals in the rat substantia nigra: an immunocytochemical study with optical and electron microscopic techniques J. Comp. Neurol. 28 1989 397 415
47. W.G. Mayhan Nitric oxide donor-induced increase in permeability of the blood-brain barrier Brain Res. 866 2000 101 108
48. M. Mitkovski, F.E. Padovan-Neto, R. Raisman-Vozari, L. Ginestet, C.A. Da-Silva, and E.A. Del-Bel Investigations into potential extrasynaptic communication between the dopaminergic and nitrergic systems Front. Physiol. 3 2012 372 10.3389/fphys.2012.00372
49. B.J. Morris, C.S. Simpson, S. Mundell, K. Maceachern, H.M. Johnston, and A.M. Nolan Dynamic changes in NADPH-diaphorase staining reflect activity of nitric oxide synthase: evidence for a dopaminergic regulation of striatal nitric oxide release Neuropharmacology 36 11 and 12 1997 1589 1599
50. A.P. Nisbet, O.J. Foster, A. Kingsbury, A.J. Lees, and C.D. Marsden Nitric oxide synthase mRNA expression in human subthalamic nucleus, striatum and globus pallidus: implications for basal ganglia function Brain Res. Mol. Brain Res. 22 1-4 1994 329 332
51. T.J. O'Dell, R.D. Hawkins, E.R. Kandel, and O. Arancio Tests of the roles of two diffusible substances in long-term potentiation: evidence for nitric oxide as a possible early retrograde messenger Proc. Natl. Acad. Sci. USA 88 24 1991 11285 11289
52. W.H. Oertel, and E. Mugnaini Immunocytochemical studies of GABAergic neurons in rat basal ganglia and their relations to other neuronal systems Neurosci. Lett. 47 1984 233 238
53. D.E. Oorschot Total number of neurons in the neostriatal, pallidal, subthalamic, and substantia nigral nuclei of the rat basal ganglia: a stereological study using the cavalieri and optical disector methods J. Comp. Neurol. 366 4 1996 580 599
54. D.J. Park, and A.R. West Regulation of striatal nitric oxide synthesis by local dopamine and glutamate interactions J. Neurochem. 111 6 2009 1457 1465
55. G. Paxinos, and C. Watson The Rat Brain in Stereotaxic Coordinates 1986 Academic Press San Diego
56. N. Pitsikas, S. Tsitsirigou, S. Zisopoulou, and N. Sakellaridis The 5-HT1A receptor and recognition memory. Possible modulation of its behavioral effects by the nitrergic system Behav. Brain Res. 159 2 2005 287 293
57. A.E. Pollack, S,M. Turgeon, and J.S. Fink Apomorphine priming alters the response of striatal outflow pathways to D2 agonist stimulation in 6-hydroxydopamine-lesioned rats Neuroscience 79 1 1997 79 93
58. S. Przedborski, V. Jackson-Lewis, M. Vila, D.C. Wu, P. Teismann, K. Tieu, D.K. Choi, and O. Cohen Free radical and nitric oxide toxicity in Parkinson's disease Adv. Neurol. 91 2003 83 94
59. D.B. Putterman, A.C. Munhall, L.B. Kozell, J.K. Belknap, and S.W. Johnson Evaluation of levodopa dose and magnitude of dopamine depletion as risk factors for levodopa-induced dyskinesia in a rat model of Parkinson's disease J. Pharmacol. Exp. Ther. 323 2007 277 284
60. P. Rauhala, T. Andoh, and C.C. Chiueh Neuroprotective properties of nitric oxide and S-nitrosoglutathione Toxicol. Appl. Pharm. 207 1 2005 91 95
61. J. Rodrigo, D.R. Springall, O. Uttenthal, M.L. Bentura, F. Abadia-Molina, V. Riveros-Moreno, R. Martínez-Murillo, J.M. Polak, and S. Moncada Localization of nitric oxide synthase in the adult rat brain Philos. Trans. R. Soc. Lond. B. Biol. Sci. 345 1312 1994 175 221
62. B. Rosenkranz, B.R. Winkelmann, and M.J. Parnham Clinical pharmacokinetics of molsidomine Clin. Pharmacokinet. 30 1996 372 384
63. F. Rothe, U. Canzler, and G. Wolf Subcellular localization of the neuronal isoform of nitric oxide synthase in the rat brain: a critical evaluation Neuroscience 83 1998 259 269
64. C. Rouillard, P.J. Bedard, P. Falardeau, and T. Dipaolo Behavioral and biochemical evidence for a different effect of repeated administration of l-dopa and bromocriptine on denervated versus non-denervated striatal dopamine receptors Neuropharmacology 26 1987 1601 1606
65. S. Sammut, A. Dec, D. Mitchell, J. Linardakis, M. Ortiguela, and A.R. West Phasic dopaminergic transmission increases NO efflux in the rat dorsal striatum via a neuronal NOS and a dopamine D(1/5) receptor-dependent mechanism Neuropsychopharmacology 31 2006 493 505
66. S. Sammut, K.E. Bray, and A.R. West Dopamine D2 receptor-dependent modulation of striatal NO synthase activity Psychopharmacology 191 2007 793 803
67. G. Sancesario, M. Giorgi, V. D'Angelo, A. Modica, A. Martorana, M. Morello, C.P. Bengtson, and G. Bernardi Down-regulation of nitrergic transmission in the rat striatum after chronic nigrostriatal deafferentation Eur. J. Neurosci. 20 4 2004 989 1000
68. R.K. Schwarting, and J.P. Huston Unilateral 6-hydroxydopamine lesions of meso-striatal dopamine neurons and their physiological sequelae Prog. Neurobiol. 49 3 1996 215 266
69. R. Spessert, and E. Layes Fixation conditions affect the intensity but not the pattern of NADPH-diaphorase staining as a marker for neuronal nitric oxide synthase in rat olfactory bulb J. Histochem. Cytochem. 42 10 1994 1309 1315
70. D.C. Sterio The unbiased estimation of number and sizes of arbitrary particles using the disector J. Microsc. 134 1984 127 136
71. M. Tomiyama, F. Mori, T. Kimura, N. Ichinohe, K. Wakabayashi, M. Matsunaga, and M. Baba Hypertrophy of medial globus pallidus and substantia nigra reticulata in 6-hydroxydopamine-lesioned rats treated with l-DOPA: implication for l-DOPA-induced dyskinesia in Parkinson's disease Neuropathology 24 4 2004 290 295
72. K. Tsou, G.L Snyder, and P. Greengard Nitric oxide/cGMP pathway stimulates phosphorylation of DARPP-32, a dopamine- and cAMP-regulated phosphoprotein, in the substantia nigra Proc. Natl. Acad. Sci. USA 90 1993 3462 3465
73. S.R. Vincent, and H. Kimura Histochemical mapping of nitric oxide synthase in the rat brain Neuroscience 46 4 1992 755 784
74. A.R. West, M.P. Galloway, and A.A. Grace Regulation of striatal dopamine neurotransmission by nitric oxide: effector pathways and signaling mechanisms Synapse 44 4 2002 227 245
75. A.R. West, and K.Y. Tseng Nitric oxide-soluble guanylyl cyclase-cyclic GMP signaling in the striatum: new targets for the treatment of Parkinson's disease? Front. Syst. Neurosci. 5 2011 55 10.3389/fnsys.2011.00055